186 related articles for article (PubMed ID: 20220258)
41. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
[TBL] [Abstract][Full Text] [Related]
42. Oral candidal carriage correlates with CD4
Sah P; Patel P; Chandrashekar C; Martena S; Ballal M; Hegde M; Guddattu V; Murdoch C; Sharma M; Radhakrishnan R
J Investig Clin Dent; 2019 Nov; 10(4):e12438. PubMed ID: 31313889
[TBL] [Abstract][Full Text] [Related]
43. Estimation and correlation of serum and salivary glucose and immunoglobulin A levels and salivary candidal carriage in diabetic and non-diabetic patients.
Hegde SS; Sattur AP; Bargale AB; Rao GS; Shetty RS; Kulkarni RD; Ajantha GS
J Dent Res Dent Clin Dent Prospects; 2020; 14(4):206-213. PubMed ID: 33575008
[No Abstract] [Full Text] [Related]
44. The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon.
Ambe NF; Longdoh NA; Tebid P; Bobga TP; Nkfusai CN; Ngwa SB; Nsai FS; Cumber SN
Pan Afr Med J; 2020; 36():23. PubMed ID: 32774600
[TBL] [Abstract][Full Text] [Related]
45. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
46. Molecular analysis of fungal populations in patients with oral candidiasis using internal transcribed spacer region.
Ieda S; Moriyama M; Takeshita T; Maehara T; Imabayashi Y; Shinozaki S; Tanaka A; Hayashida JN; Furukawa S; Ohta M; Yamashita Y; Nakamura S
PLoS One; 2014; 9(6):e101156. PubMed ID: 24979710
[TBL] [Abstract][Full Text] [Related]
47. Candida species diversity and antifungal susceptibility patterns in oral samples of HIV/AIDS patients in Baja California, Mexico.
Clark-Ordóñez I; Callejas-Negrete OA; Aréchiga-Carvajal ET; Mouriño-Pérez RR
Med Mycol; 2017 Apr; 55(3):285-294. PubMed ID: 27630251
[TBL] [Abstract][Full Text] [Related]
48. Salivary glucose levels and oral candidal carriage in Type 2 diabetics.
Bhattacharyya A; Chandra S; Singh A; Raj V; Gupta B
J Oral Biol Craniofac Res; 2018; 8(3):158-164. PubMed ID: 30191100
[TBL] [Abstract][Full Text] [Related]
49. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L
J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
[TBL] [Abstract][Full Text] [Related]
50. Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.
Costa CR; de Lemos JA; Passos XS; de Araújo CR; Cohen AJ; Souza LK; Silva Mdo R
Mycopathologia; 2006 Jul; 162(1):45-50. PubMed ID: 16830191
[TBL] [Abstract][Full Text] [Related]
51. Susceptibility of candida isolates from denture-related stomatitis to antifungal agents in vitro.
Dorocka-Bobkowska B; Konopka K
Int J Prosthodont; 2007; 20(5):504-6. PubMed ID: 17944341
[TBL] [Abstract][Full Text] [Related]
52. Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance.
Salvia AC; Figueiredo MS; Braga JA; Pereira DF; Brighenti FL; Koga-Ito CY
J Oral Pathol Med; 2013 Aug; 42(7):570-5. PubMed ID: 23278631
[TBL] [Abstract][Full Text] [Related]
53. Candidal carriage predicts candidiasis during topical immunosuppressive therapy: a preliminary retrospective cohort study.
Tejani S; Sultan A; Stojanov I; Woo SB
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):448-54. PubMed ID: 27567434
[TBL] [Abstract][Full Text] [Related]
54. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant.
Kicklighter SD; Springer SC; Cox T; Hulsey TC; Turner RB
Pediatrics; 2001 Feb; 107(2):293-8. PubMed ID: 11158461
[TBL] [Abstract][Full Text] [Related]
55. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N
J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
[TBL] [Abstract][Full Text] [Related]
56. In vitro Post-Antifungal Effect of Posaconazole and Its Impact on Adhesion-Related Traits and Hemolysin Production of Oral Candida dubliniensis Isolates.
Ellepola ANB; Dassanayake RS; Khan Z
Med Princ Pract; 2019; 28(6):552-558. PubMed ID: 31247626
[TBL] [Abstract][Full Text] [Related]
57. Occurrence of oral Candida colonization and its risk factors among patients with malignancies in China.
Sun H; Chen Y; Zou X; Li H; Yin X; Qin H; Liu R; Yu C; Li Q; Yu K; Han X; Zou J; Ge C; Han L
Clin Oral Investig; 2016 Apr; 20(3):459-67. PubMed ID: 26220512
[TBL] [Abstract][Full Text] [Related]
58. Carriage of Candida species in the oral cavity in diabetic patients: relationship to glycaemic control.
Fisher BM; Lamey PJ; Samaranayake LP; MacFarlane TW; Frier BM
J Oral Pathol; 1987 May; 16(5):282-4. PubMed ID: 3116189
[TBL] [Abstract][Full Text] [Related]
59. The relationship between colonisation, secretor status and in-vitro adhesion of Candida albicans to buccal epithelial cells from diabetics.
Darwazeh AM; Lamey PJ; Samaranayake LP; MacFarlane TW; Fisher BM; Macrury SM; MacCuish AC
J Med Microbiol; 1990 Sep; 33(1):43-9. PubMed ID: 2231671
[TBL] [Abstract][Full Text] [Related]
60. Oral candidosis--clinical challenges of a biofilm disease.
Rautemaa R; Ramage G
Crit Rev Microbiol; 2011 Nov; 37(4):328-36. PubMed ID: 21777047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
